Laboratoires Griffon Private Limited

Laboratoires Griffon Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U24239WB1947PTC015405 Incorporated 31 May 1947 ROC Kolkata HQ Kolkata, West Bengal, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2024
₹161.12 Cr
▲ 8% YoY
Net profit · FY 2024
₹9.04 Cr
Net margin 5.6%
EBITDA · FY 2024
₹15.16 Cr
EBITDA margin 9.4%
Authorised capital
₹95 Lakh
Registered with MCA
Paid-up capital
₹32.06 Lakh
Issued & subscribed
Open charges
₹1 Lakh
Secured borrowings
Company age
79 yrs
Est. 1947
Employees · EPFO
86
Provident fund records

About Laboratoires Griffon Private Limited

Data last updated:

Laboratoires Griffon Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 1947 and has been in existence for over 79 years.

Its director Postel Pascal and family are #893 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB1947PTC015405. Its GSTIN is 07AAACL4591N1Z2 (Delhi). The company holds 16 GST registrations, of which 13 are active.

The company has an authorised share capital of ₹95 Lakh and a paid-up capital of ₹32.06 Lakh. It was formerly known as Laboratoires Griffon Limited. It is led by directors including Errol James Desouza and Jagdish Purushottamdas Mehta.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 40B Princep Street, Kolkata, West Bengal, India – 700072.

As per the financials filed for FY 2024, the company reported a revenue of ₹161.12 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹9.04 Cr (net margin 5.6%) and EBITDA of ₹15.16 Cr (EBITDA margin 9.4%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 6% over five years.

The company has about 86 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹1 Lakh on record. Court records list 54 cases involving the company, including 50 filed by the company and 4 filed against it; 26 cases are pending. The company has 4 deals on record (4 secondary share transfers); the latest was in August 2011. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 smaller; the largest is Elysium Pharmaceuticals Ltd with revenue of ₹159.55 Cr. The company has 3 MSME Form 1 returns on record between 2019 and 2020, listing 23 overdue payments to 15 micro and small suppliers.

Laboratoires Griffon Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0150199). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website francoindian.com.

Company details

CIN U24239WB1947PTC015405
Registration Number 015405
Incorporation Date 31 May 1947
ROC Kolkata
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0150199

Recognitions & Rankings of Laboratoires Griffon

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-19-0150199
India's Richest People 2026 edition · 1 director · Source: Hurun India

Contact details

Laboratoires Griffon Private Limited's registered office is in Kolkata, West Bengal. Its website is francoindian.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    40B Princep Street, Kolkata, West Bengal, India – 700072
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Laboratoires Griffon Private Limited, buy the company report.

Comprehensive company report
Laboratoires Griffon Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Laboratoires Griffon is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Laboratoires Griffon Private Limited, buy the company report.

Financials of Laboratoires Griffon Private Limited

FY 2025 filings available

Laboratoires Griffon Private Limited reported revenue of ₹161.12 Cr (up 8% YoY) for FY 2024.

Revenue · FY 2024
₹161.12 Cr ▲ 8%
Net profit · FY 2024
₹9.04 Cr margin 5.6%
EBITDA · FY 2024
₹15.16 Cr margin 9.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 10%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 20%
5 years · compounded
▲ 10%

Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 8% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹15.16 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹9.04 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin9.4%
Net Profit Margin5.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Laboratoires Griffon Private Limited, buy the company report.

Board of directors of Laboratoires Griffon Private Limited

Laboratoires Griffon has 8 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Errol James DesouzaDirector14 Jan 20251 Years 10 MonthsCurrent
Jagdish Purushottamdas MehtaDirector17 Dec 200322 Years 11 MonthsCurrent
Santoshkumar GuptaDirector11 Dec 200124 Years 11 MonthsCurrent
Nelson Mathew LopesDirector30 Jan 20188 Years 9 MonthsCurrent
Vijay Laxman BadgujarDirector28 Apr 20233 Years 6 MonthsCurrent
Rajesh Tribhuvan SinghDirector23 Feb 20215 Years 8 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

Laboratoires Griffon Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Laboratoires Griffon Private Limitedthis company₹161.12 Cr (FY 2024)₹9.04 Cr5.6%8.0%Kolkata, West Bengal, India
Elysium Pharmaceuticals Ltd₹159.55 Cr (FY 2024)-26.0%Vadodara, Gujarat, India
VHB Medi Sciences Limited₹159.28 Cr (FY 2025)14.0%Kandivlai West, Maharashtra, India
Jenburkt Pharmaceuticals Ltd₹158.41 Cr (FY 2025)8.0%Mumbai, Maharashtra, India
Wardex Pharmaceuticals Private Limited₹158.1 Cr (FY 2025)8.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Laboratoires Griffon Private Limited, buy the company report.

Auditor

Laboratoires Griffon Private Limited is audited by M/s. N. Sarkar & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M/s. N. Sarkar & Co.FY 2023301075E

Shareholding

The shareholding of Laboratoires Griffon Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Laboratoires Griffon Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.01 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 May 2019100268130Others₹1 LakhOpen

Total charge records: 1 View all charges

Deals & funding

Laboratoires Griffon Private Limited has 4 deals on record (4 secondary share transfers); the latest was in August 2011.

Total deals
4
Secondary share transfers
4

Deals on record (4 of 4)

WhenDealAmountParties
Aug 2011Secondary share transferUndisclosedBuyer: Franco-Indian Holdings Private Limited
Seller: Medibest Investments Private Limited
Jun 2008Secondary share transferUndisclosedBuyer: Ward Pharmaceuticals Limited, an individual
Seller: Waregoods Limited, Franco Indian Research Private Limited , Franco Indian Medicare Pvt Ltd
Nov 2007Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Jun 2007Secondary share transferUndisclosedBuyer: Waregoods Limited
Seller: Dolphin Pharmaceutical

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Laboratoires Griffon Private Limited has 3 MSME Form 1 returns on record between 2019 and 2020, listing 23 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 15)

SupplierAmount dueDue sinceReported on
Mike Offset
an individual supplier
an individual supplier
Bombay Carbon and Metcaps Private Limited
Ven Petrochem & Pharma (India) Private Limited

To see the full MSME payment records of Laboratoires Griffon Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Laboratoires Griffon has 16 GST registrations: 13 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
16
Active
13
Cancelled / inactive
3
GSTINStateStatusRegistered on
07AAACL4591N1Z2DelhiActive01 Jul 2017
08AAACL4591N1Z0RajasthanActive01 Jul 2017
09AAACL4591N1ZYUttar PradeshActive01 Jul 2017
10AAACL4591N1ZFBiharActive01 Jul 2017

To see the full GST registrations and return filing status of Laboratoires Griffon Private Limited, buy the company report.

Recent activity

Laboratoires Griffon Private Limited has 19 board changes on record since 2001: 8 appointments and 11 cessations. The latest: Errol James Desouza was appointed as Director on 14 Jan 2025.

AGM
Laboratoires Griffon Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Laboratoires Griffon Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Appointed
Errol James Desouza was appointed as Director.
Ceased
Vijay Laxman Badgujar ceased to be Additional Director.
Appointed
Vijay Laxman Badgujar was appointed as Director.
Ceased
Pascal Postel ceased to be Additional Director.
Ceased
Pradeep Yashvantrao Sarode ceased to be Additional Director.
Ceased
Rajesh Tribhuvan Singh ceased to be Additional Director.
Ceased
Noel Christopher Amanna ceased to be Director Appointed In Casual Vacancy.
Appointed
Rajesh Tribhuvan Singh was appointed as Director.
Appointed
Pascal Postel was appointed as Director.
Charges
A charge with Others amounted to Rs. 1.00 Lakh with Charge ID 100268130 was registered on 30 May 2019.

11 earlier events are in the company report.

Frequently asked questions

Laboratoires Griffon is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 1947 (79+ years old) and is registered under CIN U24239WB1947PTC015405.

Laboratoires Griffon has 8 current directors:

The latest financial statements of Laboratoires Griffon on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Laboratoires Griffon is 07AAACL4591N1Z2, registered in Delhi. The company has 16 GST registrations in all, of which 13 are active and 3 are cancelled or inactive. Other active GSTINs include 08AAACL4591N1Z0 (Rajasthan), 09AAACL4591N1ZY (Uttar Pradesh), 10AAACL4591N1ZF (Bihar).

The CIN (Corporate Identification Number) of Laboratoires Griffon is U24239WB1947PTC015405. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Laboratoires Griffon has 54 court cases on record: 50 filed by the company and 4 filed against it. 26 are pending. Most are in the high courts.

Laboratoires Griffon was incorporated on 31 May 1947, making it 79+ years old. It is registered with the Registrar of Companies, Kolkata.

Laboratoires Griffon has 4 deals on record (4 secondary share transfers); the latest was in August 2011.

The peers of Laboratoires Griffon by revenue are Elysium Pharmaceuticals Ltd, VHB Medi Sciences Limited, Jenburkt Pharmaceuticals Ltd, Wardex Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Errol James Desouza was appointed as Director on 14 Jan 2025. Vijay Laxman Badgujar ceased to be Additional Director on 28 Sep 2023. Vijay Laxman Badgujar was appointed as Director on 28 Apr 2023. Laboratoires Griffon has 19 board changes on record in total.

Yes, Laboratoires Griffon is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0150199).

Laboratoires Griffon has 3 MSME Form 1 returns on record between 2019 and 2020, listing 23 overdue payments to 15 micro and small suppliers. The latest return was filed on 12 Aug 2020.